Journal article

Romosozumab/CDP7851 for the treatment of osteoporosis

Ie-Wen Sim, Peter R Ebeling

Expert Review of Endocrinology & Metabolism | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | Published : 2015

University of Melbourne Researchers


Funding Acknowledgements

The authors were supported by Monash University and National Health and Medical Research Council of Australia. PR Ebeling has received research funding from Amgen, Merck, Novartis, and Eli-Lilly and honoraria from Merck, Amgen, Pfizer, ViiV Healthcare, and GlaxoSmithKline. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.